Mismatch repair deficiency predicts response to HER2 blockade in HER2-negative breast cancer
Resistance to endocrine treatment in ER+/HER2- breast cancer patients remains a significant clinical problem. Here, the authors demonstrate that loss of the MutL mismatch repair complex can serve as a first-in-class predictive biomarker for combinatorial inhibition of HER2 to overcome the emergence...
Saved in:
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | article |
| Language: | EN |
| Published: |
Nature Portfolio
2021
|
| Subjects: | |
| Online Access: | https://doaj.org/article/65ef3b7f9a184674b715885b4857dafc |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|